NervGen Pharma Dividends
NGEN Stock | CAD 3.11 0.21 7.24% |
Dividend Paid And Capex Coverage Ratio is likely to drop to -83.88 in 2024. NervGen Pharma's past performance could be the main factor of why investors trade NervGen Pharma Corp stock today. Investors should clearly understand every aspect of the NervGen Pharma dividend schedule, including its future sustainability, and how it might impact an overall investment strategy. This tool is helpful to digest NervGen Pharma's dividend schedule and payout information. NervGen Pharma Corp dividends can also provide a clue to the current valuation of NervGen Pharma.
Last Reported | Projected for Next Year | ||
Dividend Paid And Capex Coverage Ratio | (79.88) | (83.88) |
NervGen |
Investing in stocks that pay dividends is one of many strategies that are good for long-term investments. Ex-dividend dates are significant because investors in NervGen Pharma must own a stock before its ex-dividend date to receive its next dividend.